Beta-carboline sulphonylurea derivatives as EP4 receptor antagonists

Details for Australian Patent Application No. 2009295308 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Berthelette, Carl; Boyd, Michael; Burch, Jason; Dufresne, Claude; Farand, Julie; Han, Yongxin; Sturino, Claudio F.

Agent Spruson & Ferguson

Pub. Number AU-A-2009295308

PCT Pub. Number WO2010/034110

Priority 61/194,144 25.09.08 US

Filing date 22 September 2009

Wipo publication date 1 April 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

7 April 2011 PCT application entered the National Phase

  PCT publication WO2010/034110 Priority application(s): WO2010/034110

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009295311-Injection of liquid into boreholes, with suckback pulsing

2009295286-Winding insulation arrangement for axial flux machines